SCHEMBL26435211

SCHEMBL26435211

c1ccc(-c2cccc(-c3ccc(-c4nc(-c5ccc6c(c5)oc5ccccc56)nc(-c5cccc6ccc7ccccc7c56)n4)cc3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
MAPT P10636 4/20 0.39
KDM4E B2RXH2 3/20 0.39
HPGD P15428 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
MAPK1 P28482 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
ATM Q13315 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
ABCG2 Q9UNQ0 4/20 0.37
PLA2G2A P14555 3/20 0.37
PLA2G4A P47712 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435193 0.99 TDP1 (0.38) ALDH1A1MAPTKDM4EHPGDTDP1
SCHEMBL26435213 0.98 ALDH1A1 (0.40) ALDH1A1MAPTKDM4EHPGDTDP1
SCHEMBL26435190 0.98 ALDH1A1 (0.40) ALDH1A1MAPTKDM4EHPGDTDP1
SCHEMBL24307055 0.96 ALDH1A1 (0.41) ALDH1A1MAPTKDM4EHPGDTDP1
SCHEMBL25817823 0.95 HCRTR1 (0.37) ALDH1A1MAPTKDM4EHPGDTDP1
SCHEMBL26435214 0.95 TDP1 (0.37) ALDH1A1MAPTKDM4EHPGDTDP1
SCHEMBL26435511 0.95 KDM4E (0.39) ALDH1A1MAPTKDM4EHPGDTDP1
SCHEMBL26435510 0.94 ALDH1A1 (0.39) ALDH1A1MAPTKDM4EHPGDTDP1
SCHEMBL26435236 0.93 PLA2G2A (0.40) ALDH1A1MAPTKDM4EHPGDTDP1
SCHEMBL26435199 0.93 TDP1 (0.42) ALDH1A1MAPTKDM4EHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALDH1A1 1532/4885MAPT 2425/4885KDM4E 1841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.